Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+204.2%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

3Y CAGR
+204.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
28.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202553.23%
2024-13.63%
2023-10.45%
20221.89%
2021-60.26%
2020-189.54%
20190.00%